Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
GrantStock Option · Derivative | 20,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 22 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-08-10 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F10 · derivative.exercise_date: The option is exercisable to the extent of 6,667 shares on each of August 10, 2018 and August 10, 2019, and 6,666 shares on August 10, 2020. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
Disposition to issuerStock Option · Derivative | 20,000 | Not disclosed Strike: $3.35 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 21 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2027-08-10 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F10 · derivative.exercise_date: The option is exercisable to the extent of 6,667 shares on each of August 10, 2018 and August 10, 2019, and 6,666 shares on August 10, 2020. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
GrantStock Option · Derivative | 30,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 20 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2027-07-12 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F9 · derivative.exercise_date: The option is exercisable to the extent of 10,000 shares on each of July 12, 2018, July 12, 2019 and July 12, 2020. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
Disposition to issuerStock Option · Derivative | 30,000 | Not disclosed Strike: $2.80 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 19 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2027-07-12 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F9 · derivative.exercise_date: The option is exercisable to the extent of 10,000 shares on each of July 12, 2018, July 12, 2019 and July 12, 2020. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
GrantStock Option · Derivative | 40,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 18 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2026-06-10 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F8 · derivative.exercise_date: The option is exercisable to the extent of 13,334 shares on June 10, 2017 and 13,333 shares on each of June 10, 2018 and June 10, 2019. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
Disposition to issuerStock Option · Derivative | 40,000 | Not disclosed Strike: $3.73 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 17 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2026-06-10 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F8 · derivative.exercise_date: The option is exercisable to the extent of 13,334 shares on June 10, 2017 and 13,333 shares on each of June 10, 2018 and June 10, 2019. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
GrantStock Option · Derivative | 25,500 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 16 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,500 Underlying: Common Stock · 25,500 shares Expires 2025-09-04 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F7 · derivative.exercise_date: The option is exercisable to the extent of 8,500 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
Disposition to issuerStock Option · Derivative | 25,500 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 15 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,500 shares Expires 2025-09-04 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F7 · derivative.exercise_date: The option is exercisable to the extent of 8,500 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
GrantStock Option · Derivative | 10,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 14 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2024-10-23 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F6 · derivative.exercise_date: The option is exercisable to the extent of 3,334 shares on October 23, 2015 and 3,333 shares on each of October 23, 2016 and October 23, 2017. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
Disposition to issuerStock Option · Derivative | 10,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 13 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2024-10-23 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F6 · derivative.exercise_date: The option is exercisable to the extent of 3,334 shares on October 23, 2015 and 3,333 shares on each of October 23, 2016 and October 23, 2017. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
GrantStock Option · Derivative | 6,250 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 12 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires 2024-02-18 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F5 · derivative.exercise_date: The option is exercisable to the extent of 2,084 shares on February 18, 2014, and 2,083 shares on each of February 18, 2015 and February 18, 2016. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
Disposition to issuerStock Option · Derivative | 6,250 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 11 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,250 shares Expires 2024-02-18 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F5 · derivative.exercise_date: The option is exercisable to the extent of 2,084 shares on February 18, 2014, and 2,083 shares on each of February 18, 2015 and February 18, 2016. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
GrantStock Option · Derivative | 4,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 10 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2023-10-04 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 2,000 shares on each of October 4, 2013 and October 4, 2014. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
Disposition to issuerStock Option · Derivative | 4,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 9 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2023-10-04 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 2,000 shares on each of October 4, 2013 and October 4, 2014. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
GrantStock Option · Derivative | 2,500 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 8 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2022-12-07 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 1,250 shares on each of December 7, 2012 and December 7, 2013. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
Disposition to issuerStock Option · Derivative | 2,500 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 7 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2022-12-07 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 1,250 shares on each of December 7, 2012 and December 7, 2013. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
GrantStock Option · Derivative | 1,500 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 6 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2022-02-09 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F2 · derivative.exercise_date: The option is exercisable to the extent of 750 shares on each of February 10, 2012 and February 10, 2013. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
Disposition to issuerStock Option · Derivative | 1,500 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 5 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2022-02-09 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F2 · derivative.exercise_date: The option is exercisable to the extent of 750 shares on each of February 10, 2012 and February 10, 2013. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
GrantStock Option · Derivative | 300 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 4 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 Underlying: Common Stock · 300 shares Expires 2021-04-20 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F1 · derivative.exercise_date: The option is exercisable to the extent of 100 shares on each of April 21, 2011, April 21, 2012 and April 21, 2013. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
Disposition to issuerStock Option · Derivative | 300 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 3 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 300 shares Expires 2021-04-20 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F1 · derivative.exercise_date: The option is exercisable to the extent of 100 shares on each of April 21, 2011, April 21, 2012 and April 21, 2013. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
GrantStock Option · Derivative | 4,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 2 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2020-12-14 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 21:15 UTC |
Clyde Mandy D.VP of Operations
|
Disposition to issuerStock Option · Derivative | 4,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007658 · doc1.xml · derivative · entry 1 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2020-12-14 F12 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. Read SEC document |
| March 25, 2019 Filed Mar 27, 2019 17:11 UTC |
CATELL ROBERT BDirector
|
GrantStock Option · Derivative | 75,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007726 · doc1.xml · derivative · entry 15 CATELL ROBERT B · CIK 0001195325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-10-29 F5 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020. Read SEC document |
| March 25, 2019 Filed Mar 27, 2019 17:11 UTC |
CATELL ROBERT BDirector
|
Disposition to issuerStock Option · Derivative | 75,000 | Not disclosed Strike: $1.23 | Not disclosed |
DisclosureSEC source: 0001567619-19-007726 · doc1.xml · derivative · entry 14 CATELL ROBERT B · CIK 0001195325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires 2028-10-29 F5 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020. Read SEC document |
| March 25, 2019 Filed Mar 27, 2019 17:11 UTC |
CATELL ROBERT BDirector
|
GrantStock Option · Derivative | 100,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007726 · doc1.xml · derivative · entry 12 CATELL ROBERT B · CIK 0001195325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-06-23 F5 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 33,334 shares on June 23, 2017, and 33,333 shares on each of June 23, 2018 and June 23, 2019. Read SEC document |
| March 25, 2019 Filed Mar 27, 2019 17:11 UTC |
CATELL ROBERT BDirector
|
Disposition to issuerStock Option · Derivative | 100,000 | Not disclosed Strike: $3.35 | Not disclosed |
DisclosureSEC source: 0001567619-19-007726 · doc1.xml · derivative · entry 11 CATELL ROBERT B · CIK 0001195325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2027-06-23 F5 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 33,334 shares on June 23, 2017, and 33,333 shares on each of June 23, 2018 and June 23, 2019. Read SEC document |
| March 25, 2019 Filed Mar 27, 2019 17:11 UTC |
CATELL ROBERT BDirector
|
GrantStock Option · Derivative | 29,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007726 · doc1.xml · derivative · entry 7 CATELL ROBERT B · CIK 0001195325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,000 Underlying: Common Stock · 29,000 shares Expires 2026-06-10 F5 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F2 · derivative.exercise_date: The option vests to the extent of 9,667 shares on each of June 10, 2016 and June 10, 2017, and 9,666 shares on June 10, 2018. Read SEC document |
| March 25, 2019 Filed Mar 27, 2019 17:11 UTC |
CATELL ROBERT BDirector
|
Disposition to issuerStock Option · Derivative | 29,000 | Not disclosed Strike: $3.73 | Not disclosed |
DisclosureSEC source: 0001567619-19-007726 · doc1.xml · derivative · entry 6 CATELL ROBERT B · CIK 0001195325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,000 shares Expires 2026-06-10 F5 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F2 · derivative.exercise_date: The option vests to the extent of 9,667 shares on each of June 10, 2016 and June 10, 2017, and 9,666 shares on June 10, 2018. Read SEC document |
| March 25, 2019 Filed Mar 27, 2019 17:11 UTC |
CATELL ROBERT BDirector
|
GrantStock Option · Derivative | 15,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007726 · doc1.xml · derivative · entry 3 CATELL ROBERT B · CIK 0001195325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2026-02-19 F5 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F1 · derivative.exercise_date: The option vests to the extent of 5,000 shares on each of February 19, 2017, 2018 and 2019. Read SEC document |
| March 25, 2019 Filed Mar 27, 2019 17:11 UTC |
CATELL ROBERT BDirector
|
Disposition to issuerStock Option · Derivative | 15,000 | Not disclosed Strike: $3.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007726 · doc1.xml · derivative · entry 2 CATELL ROBERT B · CIK 0001195325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2026-02-19 F5 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F1 · derivative.exercise_date: The option vests to the extent of 5,000 shares on each of February 19, 2017, 2018 and 2019. Read SEC document |
| March 13, 2019 Filed May 9, 2019 20:37 UTC |
Broadrick Dale10% owner
|
PurchaseCommon Stock | 3,000 | $0.65 | $1,950.00 |
DisclosureSEC source: 0001567619-19-010301 · doc1.xml · nonDerivative · entry 4 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,171,861 Read SEC document |
| March 05, 2019 Filed May 9, 2019 20:37 UTC |
Broadrick Dale10% owner
|
PurchaseCommon Stock | 6,000 | $0.69 | $4,140.00 |
DisclosureSEC source: 0001567619-19-010301 · doc1.xml · nonDerivative · entry 3 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,168,861 Read SEC document |
| February 27, 2019 Filed May 9, 2019 20:37 UTC |
Broadrick Dale10% owner
|
PurchaseCommon Stock | 409 | $0.66 | $269.94 |
DisclosureSEC source: 0001567619-19-010301 · doc1.xml · nonDerivative · entry 2 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,162,861 Read SEC document |
| February 26, 2019 Filed May 9, 2019 20:37 UTC |
Broadrick Dale10% owner
|
PurchaseCommon Stock | 1,000 | $0.68 | $680.00 |
DisclosureSEC source: 0001567619-19-010301 · doc1.xml · nonDerivative · entry 1 Broadrick Dale · CIK 0001677513 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,162,452 Read SEC document |
| November 20, 2018 Filed Nov 20, 2018 22:08 UTC |
Desmarais John MDirector · 10% owner
|
GrantWarrant · Derivative | 400,000 | Not disclosed Strike: $1.50 | Not disclosed |
DisclosureSEC source: 0001567619-18-006777 · doc1.xml · derivative · entry 8 Desmarais John M · CIK 0001659553 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2019-12-31 F6 · price: The reported transactions involved an amendment of an outstanding warrant resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price and an extended expiration date. Read SEC document |
| November 20, 2018 Filed Nov 20, 2018 22:08 UTC |
Desmarais John MDirector · 10% owner
|
Disposition to issuerWarrant · Derivative | 400,000 | Not disclosed Strike: $4.00 | Not disclosed |
DisclosureSEC source: 0001567619-18-006777 · doc1.xml · derivative · entry 7 Desmarais John M · CIK 0001659553 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 400,000 shares Expires 2018-12-31 F6 · price: The reported transactions involved an amendment of an outstanding warrant resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price and an extended expiration date. Read SEC document |
| November 20, 2018 Filed Nov 20, 2018 22:08 UTC |
Desmarais John MDirector · 10% owner
|
GrantWarrant · Derivative | 444,444 | Not disclosed Strike: $1.50 | Not disclosed |
DisclosureSEC source: 0001567619-18-006777 · doc1.xml · derivative · entry 6 Desmarais John M · CIK 0001659553 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 444,444 Underlying: Common Stock · 444,444 shares Expires 2019-12-31 F6 · price: The reported transactions involved an amendment of an outstanding warrant resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price and an extended expiration date. Read SEC document |
| November 20, 2018 Filed Nov 20, 2018 22:08 UTC |
Desmarais John MDirector · 10% owner
|
Disposition to issuerWarrant · Derivative | 444,444 | Not disclosed Strike: $4.00 | Not disclosed |
DisclosureSEC source: 0001567619-18-006777 · doc1.xml · derivative · entry 5 Desmarais John M · CIK 0001659553 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 444,444 shares Expires 2018-12-31 F6 · price: The reported transactions involved an amendment of an outstanding warrant resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant at a reduced exercise price and an extended expiration date. Read SEC document |
| October 29, 2018 Filed Oct 30, 2018 16:26 UTC |
Tonna Paul JudeDirector
|
GrantStock Option · Derivative | 75,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001567619-18-004780 · doc1.xml · derivative · entry 10 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-10-29 F7 · derivative.exercise_date: The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020. Read SEC document |
| October 29, 2018 Filed Oct 30, 2018 18:15 UTC |
CATELL ROBERT BDirector
|
GrantStock Option · Derivative | 75,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001567619-18-004802 · doc1.xml · derivative · entry 11 CATELL ROBERT B · CIK 0001195325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-10-29 F4 · derivative.exercise_date: The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020. Read SEC document |
| October 29, 2018 Filed Oct 30, 2018 20:51 UTC |
Weinreb MarkDirector · CEO and Chairman of the Board · 10% owner
|
GrantStock Option · Derivative | 275,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001567619-18-004791 · doc1.xml · derivative · entry 11 Weinreb Mark · CIK 0001527212 · Director · CEO and Chairman of the Board · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,000 Underlying: Common Stock · 275,000 shares Expires 2028-10-29 F9 · derivative.exercise_date: The option is exercisable to the extent of 91,667 shares on each of October 29, 2018 and October 29, 2019, and 91,666 shares on October 29, 2020. Read SEC document |
| October 29, 2018 Filed Oct 30, 2018 20:37 UTC |
Desmarais John MDirector · 10% owner
|
GrantStock Option · Derivative | 75,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001567619-18-004784 · doc1.xml · derivative · entry 13 Desmarais John M · CIK 0001659553 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-10-29 F5 · derivative.exercise_date: The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020. Read SEC document |
| October 29, 2018 Filed Oct 31, 2018 16:02 UTC |
Paccasassi RobertVP, Quality and Compliance
|
GrantStock Option · Derivative | 50,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001567619-18-004864 · doc1.xml · derivative · entry 4 Paccasassi Robert · CIK 0001751339 · VP, Quality and Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-10-29 F4 · derivative.exercise_date: The option is exercisable to the extent of 16,667 shares on each of October 29, 2019 and October 29, 2020, and 16,666 shares on October 29, 2021. Read SEC document |
| October 29, 2018 Filed Oct 31, 2018 20:03 UTC |
Radov A. JeffreyDirector
|
GrantStock Option · Derivative | 75,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001567619-18-004865 · doc1.xml · derivative · entry 10 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-10-29 F9 · derivative.exercise_date: The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020. Read SEC document |
| October 29, 2018 Filed Oct 31, 2018 20:02 UTC |
Ryan Charles S.Director
|
GrantStock Option · Derivative | 75,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001567619-18-004863 · doc1.xml · derivative · entry 9 Ryan Charles S. · CIK 0001624830 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-10-29 F5 · derivative.exercise_date: The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020. Read SEC document |
| October 29, 2018 Filed Oct 31, 2018 20:01 UTC |
Silva FranciscoVP of Research and Development
|
GrantStock Option · Derivative | 100,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001567619-18-004860 · doc1.xml · derivative · entry 17 Silva Francisco · CIK 0001527241 · VP of Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-10-29 F11 · derivative.exercise_date: The option is exercisable to the extent of 33,334 shares on October 29, 2019, and 33,333 shares on each of October 29, 2020 and October 29, 2021. Read SEC document |
| October 29, 2018 Filed Oct 31, 2018 20:00 UTC |
Clyde Mandy D.VP of Operations
|
GrantStock Option · Derivative | 50,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001567619-18-004859 · doc1.xml · derivative · entry 12 Clyde Mandy D. · CIK 0001527239 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-10-29 F11 · derivative.exercise_date: The option is exercisable to the extent of 16,667 shares on each of October 29, 2019 and October 29, 2020, and 16,666 shares on October 29, 2021. Read SEC document |
| October 15, 2018 Filed Oct 17, 2018 20:47 UTC |
ALSTODT LANCEEVP and Chief Strategy Officer
|
GrantStock Option · Derivative | 500,000 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001567619-18-004233 · doc1.xml · derivative · entry 1 ALSTODT LANCE · CIK 0001756228 · EVP and Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2028-10-15 F1 · derivative.exercise_date: The option vests to the extent of 100,000 shares as of October 15, 2018, 150,000 shares upon the earlier of October 15, 2019 or the date on which the initial patient recruitment for the Company's Phase II lumbar clinical trial occurs, and 250,000 shares as of October 15, 2020. Read SEC document |
| May 09, 2018 Filed May 10, 2018 10:33 UTC |
CATELL ROBERT BDirector
|
PurchaseCommon Stock | 5,000 | $2.80 | $14,000.00 |
DisclosureSEC source: 0001140361-18-022682 · doc1.xml · nonDerivative · entry 1 CATELL ROBERT B · CIK 0001195325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,866 Read SEC document |
| January 19, 2018 Filed Jan 19, 2018 22:40 UTC |
BERGSTEIN ADAM D.SVP, Planning and Business Dev
|
GrantStock Option · Derivative | 500,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001140361-18-002638 · doc1.xml · derivative · entry 2 BERGSTEIN ADAM D. · CIK 0001728666 · SVP, Planning and Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2028-01-19 F1 · derivative.exercise_date: The option vests and becomes exercisable on the date on which the initial patient recruitment for the Company's Phase II lumbar clinical trial or comparable product occurs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.